CAMZYOS: payments to doctors
Payments that named CAMZYOS as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $10.1M
- Providers
- 34,282
- Transactions
- 137,363
- Average per transaction
- $73
The per-transaction average — $73 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 34,282 providers the average total is $294, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | $10,074,422 | 99.9% |
| Bristol Myers Squibb | $14,223 | 0.1% |